Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to-intermediate HCC

ASCO 2026: Highlights and analysis

Olaparib plus pembrolizumab improves response but not PFS in BRCA-mutant pancreatic cancer

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer

Tumour-selective oncolytic adenovirus LOAd703 with chemo shows immune activation and promising responses in pancreatic cancer

Oncolytic adenovirus VCN-01 plus chemo shows promising survival benefit in metastatic pancreatic cancer